More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
About Zappy Health: Customers say they were drawn to the online provider by its low prices, its lack of subscription fees and ...
Nutrition guidelines He has said the nutrition department at the Food and Drug Administration that is ... saying it focused on symptoms of the obesity crisis rather than fixing the food system ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results